These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 16374344)
1. A network of patients with orphan retinal diseases for clinical trials: goals, structure, challenges. Weleber RG Retina; 2005 Dec; 25(8 Suppl):S66-S67. PubMed ID: 16374344 [No Abstract] [Full Text] [Related]
2. Challenges associated with clinical trials for inherited and orphan retinal diseases. Fishman GA Retina; 2005 Dec; 25(8 Suppl):S10-S12. PubMed ID: 16374308 [No Abstract] [Full Text] [Related]
3. Proceedings of the First International Symposium on Translational Clinical Research for Inherited and Orphan Retinal Diseases. November 5-7, 2004. Washington, DC, USA. Retina; 2005 Dec; 25(8 Suppl):S1-113. PubMed ID: 16509005 [No Abstract] [Full Text] [Related]
4. Design of phase III clinical trials for treatments of orphan retinal diseases: an overview of considerations. Hyman L Retina; 2005 Dec; 25(8 Suppl):S69-S71. PubMed ID: 16374346 [No Abstract] [Full Text] [Related]
5. Beyond basic research for inherited and orphan retinal diseases: successes and challenges. Chader GJ Retina; 2005 Dec; 25(8 Suppl):S15-S17. PubMed ID: 16374318 [No Abstract] [Full Text] [Related]
8. The national eye institute: translational clinical research initiatives on inherited and orphan retinal diseases: personal observations. Sieving PA Retina; 2005 Dec; 25(8 Suppl):S8-S9. PubMed ID: 16374351 [No Abstract] [Full Text] [Related]
9. Challenges in genetic testing for clinical trials of inherited and orphan retinal diseases. Stone EM Retina; 2005 Dec; 25(8 Suppl):S72-S73. PubMed ID: 16374347 [No Abstract] [Full Text] [Related]
10. The consortium project to treat RPE65 deficiency in humans. Hauswirth WW Retina; 2005 Dec; 25(8 Suppl):S60. PubMed ID: 16374340 [No Abstract] [Full Text] [Related]
11. Importance of genotyping in clinical trials of inherited and orphan retinal diseases. Dryja TP Retina; 2005 Dec; 25(8 Suppl):S74. PubMed ID: 16374348 [No Abstract] [Full Text] [Related]
12. Hurdles and opportunities for a venture capitalist investing in therapies for orphan retinal diseases. Blair JC Retina; 2005 Dec; 25(8 Suppl):S105-S108. PubMed ID: 16374312 [No Abstract] [Full Text] [Related]
18. BEST1: the Best Target for Gene and Cell Therapies. Yang T; Justus S; Li Y; Tsang SH Mol Ther; 2015 Dec; 23(12):1805-9. PubMed ID: 26388462 [TBL] [Abstract][Full Text] [Related]